Home › NCT07063056

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

Curcumin and Astaxanthin for Lowering Triglyceride Readings and Inflammation

Who can join

Ages 21 to 59 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Triglyceride reading of 140-250 mg/dL
* Age 21-59

Exclusion Criteria:

* Uncontrolled diabetes
* Hypothyroidism or other hormonal problems that have not stabilized
* Any liver diseases being actively treated
* Cancer
* Renal dialysis use
* Rheumatoid arthritis and related issues like lupus
* Inflammatory bowel disease
* Smoking
* Low blood pressure
* Having more than 5 alcoholic drinks per week
* Extreme obesity (BMI over 37)
* Pregnancy or lactation

About the study

Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.

What is being tested

• Curcumin (Longvida™) (dietary supplement)
• Half Dose Curcumin (Longvida™) (dietary supplement)
• Astaxanthin (dietary supplement)
• Placebo Control (other)

Sponsor: Medinutra LLC · Participants: 64 · Started: Jul 18, 2025

Contact the study team

• Robert DiSilvestro, Ph.D. · Phone: 6143489375

Official record on ClinicalTrials.gov — NCT07063056

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.